Company / Gross Profit
BIOMERICA INC Gross Profit History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$498.0K
FY2024
5-year range
$446.0K / $3.0M
FY2020-FY2024
Trend
-18.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 9 years, ranging from $366,285 in FY2020 to $3M in FY2021.
Based on SEC 10-K filings.
$498,000 in FY2024 with a 5-year CAGR of -17.4%.
Improved from $446,000 to $498,000 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -44.9%
- 5-Year CAGR
- -17.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -17.4%, indicating a declining trend.
- In FY2024, gross profit decreased 18.5% year-over-year.
- Peak gross profit was recorded in FY2021.
- Lowest gross profit in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $498.0K | -18.5% |
| FY2023 | $611.0K | +37.0% |
| FY2022 | $446.0K | -85.0% |
| FY2021 | $3.0M | +712.8% |
| FY2020 | $366.3K | -71.7% |
| FY2019 | $1.3M | +0.0% |
| FY2018 | $1.3M | -26.4% |
| FY2017 | $1.8M | -13.2% |
| FY2016 | $2.0M | +32.7% |
As of FY2024 · SEC Form 10-K · Last checked Jun 22, 2026